gip/glp-1 receptor agonist drugs Tirzepatide (LY3298176) is a Dual GIP and GLP-1 for Type 2 Diabetes Research Risk of pancreatic cancer associated
Pay in 4 interest-free payments of $5.32 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29





























